QGAI vs PZZA: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

PZZA has stronger fundamentals based on our AI analysis.

QGAI
Quantumzyme Corp.
STRONG SELL
98%
Confidence
VS
PZZA
PAPA JOHNS INTERNATIONAL INC
SELL
85%
Confidence

QGAI vs PZZA Fundamental Comparison

Metric QGAI PZZA
Revenue $0.0 $2.1B
Net Income $-4.4M $30.5M
Net Margin N/A 1.5%
ROE N/A N/A
ROA -7,422,923.7% 3.6%
Current Ratio 0.00x 0.82x
Debt/Equity N/A N/A
EPS $-0.11 $0.90

Green = Better metric | Red = Weaker metric

View Full QGAI Analysis →
View Full PZZA Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

QGAI vs AAPL PZZA vs MSFT QGAI vs GOOGL PZZA vs AMZN

QGAI vs PZZA: Frequently Asked Questions

Is QGAI or PZZA a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), PZZA has stronger fundamentals. QGAI is rated STRONG SELL (98% confidence) while PZZA is rated SELL (85% confidence). This is not investment advice.

How does QGAI compare to PZZA fundamentally?

Quantumzyme Corp. has ROE of N/A vs PAPA JOHNS INTERNATIONAL INC's N/A. Net margins are N/A vs 1.5% respectively.

Which stock pays higher dividends, QGAI or PZZA?

QGAI has a dividend yield of N/A or no dividend while PZZA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in QGAI or PZZA for long term?

For long-term investing, consider that QGAI has STRONG SELL rating with 98% confidence, while PZZA has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about QGAI vs PZZA?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For QGAI vs PZZA, the AI consensus favors PZZA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.